Monte Rosa Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.
/ 
Frequently asked questions
To buy Monte Rosa Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Monte Rosa Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Monte Rosa Therapeutics Inc is GLUE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Monte Rosa Therapeutics Inc has its primary listing on NASDAQ. You can trade Monte Rosa Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Monte Rosa Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Monte Rosa Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Monte Rosa Therapeutics Inc.